All employers

INC Research

Details

  • Number of employees
    1000-5000
  • Company Type
    Government
About INC Research

INC Research is a leading global contract research organization (CRO) that provides comprehensive clinical development services to the pharmaceutical and biotechnology industries. With a commitment to advancing healthcare, INC Research partners with clients to deliver innovative solutions that enhance the efficiency and effectiveness of clinical trials.

Founded on the principles of integrity and excellence, INC Research has built a reputation for its deep therapeutic expertise and operational excellence. The company offers a wide range of services, including clinical trial management, data management, biostatistics, and regulatory affairs, ensuring that clients receive tailored support throughout the drug development process.

With a strong focus on patient-centricity, INC Research prioritizes the needs of patients and their families in every aspect of its operations. The company employs advanced technologies and methodologies to streamline processes and improve patient engagement, ultimately leading to faster and more successful clinical outcomes.

INC Research operates globally, with a presence in key markets across Europe, North America, and Asia. This extensive reach allows the company to leverage diverse patient populations and local expertise, enhancing the quality and speed of clinical trials.

The vision of INC Research is to be the partner of choice for biopharmaceutical companies seeking to bring new therapies to market. By fostering collaboration and innovation, INC Research aims to transform the clinical development landscape and contribute to the advancement of medical science.

In summary, INC Research is dedicated to providing high-quality clinical research services that meet the evolving needs of the healthcare industry. Through its commitment to excellence, patient-centric approach, and global capabilities, INC Research is poised to make a significant impact on the future of drug development.

>